Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105254587A details a safer chlorination route for tianeptine sodium intermediate using industrial hydrochloric acid, ensuring high purity and supply chain stability.
Novel synthetic route for Velpatasvir Intermediate A offers high purity and yield. Ideal for reliable pharmaceutical intermediates supplier seeking cost reduction and scalable production.
Patent CN114622228B details a green electrocatalytic method for steroid intermediates, ensuring high yield, reduced waste, and reliable supply chain continuity.
Novel low-temperature FeCl3 catalyzed process reduces impurities and time for high-purity pharma intermediates manufacturing supply chain efficiency and reliability.
Patent CN110845388A reveals a novel 3-step synthesis of 7-nitroindole from o-nitroaniline. Discover cost-effective, scalable production methods for high-purity intermediates.
Novel nickel-catalyzed route for Ruxolitinib key intermediate. Reduces cost, eliminates palladium, ensures high purity for API manufacturing.
Patent CN108504701A details enzymatic synthesis of metolachlor intermediate offering high purity and scalable production for reliable agrochemical intermediate supply chains.
Novel alkaline hydrolysis method for Semaglutide backbone fragments. High purity, simplified steps, and cost-effective manufacturing for GLP-1 analog intermediates.
Novel synthesis route for Saxagliptin intermediate via CN105037245A. High purity, scalable process for DPP-4 inhibitor manufacturing supply chain optimization and cost efficiency.
Patent CN105859648B reveals high-yield Peramivir intermediate synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Discover the novel preparation method for Saxagliptin Intermediate A via patent CN111170927B. Achieve high purity and cost reduction in pharmaceutical manufacturing with our advanced process.
Advanced preparation of Silodosin intermediate via novel Friedel-Crafts route. Offers high optical purity, reduced toxicity, and scalable manufacturing for global supply chains.
Novel enzymatic route for Dapoxetine intermediate ensures high purity and scalable production. Offers significant cost reduction and supply chain reliability for global API manufacturers.
Patent CN106478515B reveals a novel method for Azilsartan intermediate synthesis, offering high purity and simplified workup for reliable pharmaceutical supply chains.
Novel palladium-free synthesis of 3-methylbenzo[d]oxazol-2(3H)-one-5-boronic acid pinacol ester. High purity >99%, total yield >81%, cost-effective API intermediate manufacturing.
Novel two-step synthesis for Vonoprazan fumarate intermediate offers high purity and cost efficiency. Reliable supply chain solution for pharmaceutical intermediates manufacturing globally.
Patent CN118878537A reveals a cost-effective 4-step route for PRMT5 inhibitor intermediates, eliminating palladium catalysts and enhancing supply chain reliability for global pharmaceutical manufacturing.
Advanced patent CN104628622A offers high-yield Saxagliptin intermediate synthesis. Ensures supply chain stability and cost efficiency for global pharma.
Patent CN113880720A reveals a novel FeCl3-catalyzed reduction for Mirabegron intermediates, offering significant cost reduction and enhanced safety for API manufacturing supply chains.
Novel NHC-Cu catalyzed route for Duloxetine intermediate offers high yield and purity. Cost-effective manufacturing solution for pharmaceutical supply chains.